Isbn: 9786630162813 - Microrna Diagnostics in Kidney Disease: Innovations and Challenges: Microrna-based Biomarkers in Chronic Kidney Disease: from Molecular Mechanisms to Clinical Applications (9 results)

ISBN: 
Refine with Advanced Search

Refine your search

  • Books (9)

  • New (9)

to

Custom price range (£)

to

  • Language: English

    Published by LAP LAMBERT Academic Publishing, 2026

    6630162811 / 9786630162813

    • Softcover

    Seller: PBShop.store US, Wood Dale, IL, U.S.A.PBShop.store US

    5-star seller
    Contact seller

    Condition: New

    £ 51.24

     Free Shipping 
    Ships within U.S.A.

    Quantity: Over 20 available

    PAP. Condition: New. New Book. Shipped from UK. Established seller since 2000.

  • Language: English

    Published by LAP Lambert Academic Publishing, 2026

    6630162811 / 9786630162813

    • Softcover

    Seller: California Books, Miami, FL, U.S.A.California Books

    5-star seller
    Contact seller

    Condition: New

    £ 51.33

     Free Shipping 
    Ships within U.S.A.

    Quantity: Over 20 available

    Condition: New.

  • Language: English

    Published by LAP LAMBERT Academic Publishing, 2026

    6630162811 / 9786630162813

    • Softcover

    Seller: PBShop.store UK, Fairford, GLOS, United KingdomPBShop.store UK

    5-star seller
    Contact seller

    Condition: New

    £ 48.26

    £ 3.29 shipping 
    Ships from United Kingdom to U.S.A.

    Quantity: Over 20 available

    PAP. Condition: New. New Book. Shipped from UK. Established seller since 2000.

  • Language: English

    Published by LAP Lambert Academic Publishing, 2026

    6630162811 / 9786630162813

    • Softcover
    • Print on Demand

    Seller: Grand Eagle Retail, Bensenville, IL, U.S.A.Grand Eagle Retail

    5-star seller
    Contact seller

    Condition: New

    £ 51.24

     Free Shipping 
    Ships within U.S.A.

    Quantity: 1 available

    Paperback. Condition: new. Paperback. Chronic kidney disease (CKD) poses a substantial global health issue, impacting over 850 million people worldwide. Current clinical biomarkers lack sufficient sensitivity to identify early renal injury. Small non-coding RNAs (ncRNAs) have gained increasing attention as promising biomarkers for the early diagnosis and therapeutic targeting of CKD. MicroRNAs are short ncRNA molecules that modulate gene expression. Owing to their remarkable stability in biological fluids, miRNAs can be reliably detected and quantified, highlighting their potential as prognostic and diagnostic biomarkers and as targets for therapy. Aberrant miRNA expression has been implicated as a critical contributor to the initiation and progression of numerous complex human disorders, including renal diseases. Accumulating evidence indicates that miRNAs may serve as viable targets for creating new treatment approaches for CKD. Accordingly, this book shows the current knowledge regarding the significance of miRNAs in the early diagnosis and intervention of CKD, also addressing key challenges and future directions in the development of miRNA-based therapeutics for CKD treatment. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.…

  • Language: English

    Published by LAP LAMBERT Academic Publishing Jun 2026, 2026

    6630162811 / 9786630162813

    • Softcover
    • Print on Demand

    Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, GermanyBuchWeltWeit Ludwig Meier e.K.

    5-star seller
    Contact seller

    Condition: New

    £ 42.81

    £ 19.55 shipping 
    Ships from Germany to U.S.A.

    Quantity: 2 available

    Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware 64 pp. Englisch.

  • Language: English

    Published by LAP LAMBERT Academic Publishing, 2026

    6630162811 / 9786630162813

    • Softcover
    • Print on Demand

    Seller: AHA-BUCH GmbH, Einbeck, GermanyAHA-BUCH GmbH

    5-star seller
    Contact seller

    Condition: New

    £ 43.32

    £ 29.75 shipping 
    Ships from Germany to U.S.A.

    Quantity: 2 available

    Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Chronic kidney disease (CKD) poses a substantial global health issue, impacting over 850 million people worldwide. Current clinical biomarkers lack sufficient sensitivity to identify early renal injury. Small non-coding RNAs (ncRNAs) have gained increasing attention as promising biomarkers for the early diagnosis and therapeutic targeting of CKD. MicroRNAs are short ncRNA molecules that modulate gene expression. Owing to their remarkable stability in biological fluids, miRNAs can be reliably detected and quantified, highlighting their potential as prognostic and diagnostic biomarkers and as targets for therapy. Aberrant miRNA expression has been implicated as a critical contributor to the initiation and progression of numerous complex human disorders, including renal diseases. Accumulating evidence indicates that miRNAs may serve as viable targets for creating new treatment approaches for CKD. Accordingly, this book shows the current knowledge regarding the significance of miRNAs in the early diagnosis and intervention of CKD, also addressing key challenges and future directions in the development of miRNA-based therapeutics for CKD treatment. …

  • Language: English

    Published by LAP Lambert Academic Publishing, 2026

    6630162811 / 9786630162813

    • Softcover
    • Print on Demand

    Seller: CitiRetail, Stevenage, United KingdomCitiRetail

    5-star seller
    Contact seller

    Condition: New

    £ 52.49

    £ 37.00 shipping 
    Ships from United Kingdom to U.S.A.

    Quantity: 1 available

    Paperback. Condition: new. Paperback. Chronic kidney disease (CKD) poses a substantial global health issue, impacting over 850 million people worldwide. Current clinical biomarkers lack sufficient sensitivity to identify early renal injury. Small non-coding RNAs (ncRNAs) have gained increasing attention as promising biomarkers for the early diagnosis and therapeutic targeting of CKD. MicroRNAs are short ncRNA molecules that modulate gene expression. Owing to their remarkable stability in biological fluids, miRNAs can be reliably detected and quantified, highlighting their potential as prognostic and diagnostic biomarkers and as targets for therapy. Aberrant miRNA expression has been implicated as a critical contributor to the initiation and progression of numerous complex human disorders, including renal diseases. Accumulating evidence indicates that miRNAs may serve as viable targets for creating new treatment approaches for CKD. Accordingly, this book shows the current knowledge regarding the significance of miRNAs in the early diagnosis and intervention of CKD, also addressing key challenges and future directions in the development of miRNA-based therapeutics for CKD treatment. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.…

  • Language: English

    Published by LAP LAMBERT Academic Publishing Jun 2026, 2026

    6630162811 / 9786630162813

    • Softcover
    • Print on Demand

    Seller: buchversandmimpf2000, Emtmannsberg, BAYE, Germanybuchversandmimpf2000

    5-star seller
    Contact seller

    Condition: New

    £ 42.81

    £ 50.99 shipping 
    Ships from Germany to U.S.A.

    Quantity: 1 available

    Taschenbuch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Chronic kidney disease (CKD) poses a substantial global health issue, impacting over 850 million people worldwide. Current clinical biomarkers lack sufficient sensitivity to identify early renal injury. Small non-coding RNAs (ncRNAs) have gained increasing attention as promising biomarkers for the early diagnosis and therapeutic targeting of CKD. MicroRNAs are short ncRNA molecules that modulate gene expression. Owing to their remarkable stability in biological fluids, miRNAs can be reliably detected and quantified, highlighting their potential as prognostic and diagnostic biomarkers and as targets for therapy. Aberrant miRNA expression has been implicated as a critical contributor to the initiation and progression of numerous complex human disorders, including renal diseases. Accumulating evidence indicates that miRNAs may serve as viable targets for creating new treatment approaches for CKD. Accordingly, this book shows the current knowledge regarding the significance of miRNAs in the early diagnosis and intervention of CKD, also addressing key challenges and future directions in the development of miRNA-based therapeutics for CKD treatment. 64 pp. Englisch. …

  • Language: English

    Published by LAP LAMBERT Academic Publishing, 2026

    6630162811 / 9786630162813

    • Softcover
    • Print on Demand

    Seller: preigu, Osnabrück, Germanypreigu

    5-star seller
    Contact seller

    Condition: New

    £ 37.25

    £ 59.49 shipping 
    Ships from Germany to U.S.A.

    Quantity: 5 available

    Taschenbuch. Condition: Neu. MicroRNA Diagnostics in Kidney Disease: Innovations and Challenges | MicroRNA-Based Biomarkers in Chronic Kidney Disease: From Molecular Mechanisms to Clinical Applications | Weaam Gouda | Taschenbuch | Englisch | 2026 | LAP LAMBERT Academic Publishing | EAN 9786630162813 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu Print on Demand.…